Aegon Asset Management Uk PLC Edwards Lifesciences Corp Transaction History

Aegon Asset Management Uk PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$74.26 - $84.51 $445 - $507	6 Added 15.38%	45 $4,000
Q4 2022 Oct 19, 2023	SELL	$68.3 - $87.44 $409 - $524	-6 Reduced 13.33%	39 $3,000
Q4 2022 Jan 17, 2023	SELL	$68.3 - $87.44 $1.13 Million - $1.45 Million	-16,588 Reduced 99.77%	39 $3,000
Q3 2022 Oct 18, 2022	BUY	$82.37 - $107.29 $1.37 Million - $1.78 Million	16,588 Added 42533.33%	16,627 $1.38 Million
Q2 2022 Jul 12, 2022	BUY	$86.5 - $128.27 $3,373 - $5,002	39 New	39 $4,000
Q3 2020 Oct 30, 2020	SELL	$67.19 - $87.44 $2.37 Million - $3.09 Million	-35,337 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $1.36 Million - $1.81 Million	23,558 Added 200.0%	35,337 $2.44 Million
Q4 2018 Jan 14, 2019	SELL	$46.41 - $56.94 $172,552 - $211,702	-3,718 Reduced 23.99%	11,779 $1.8 Million
Q1 2018 May 09, 2018	SELL	$37.19 - $47.45 $101,417 - $129,396	-2,727 Reduced 14.96%	15,497 $2.16 Million
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $661,348 - $707,637	18,224	18,224 $1.99 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

Stay updated on Aegon Asset Management Uk PLC with notifications on news.